With fine-tuned AI models, OpenAI, Babylon aim to predict clinical trial successes

When it comes to training artificial intelligence, OpenAI and Babylon Biosciences have shown that experienced hands can help steer the programs toward greater accuracy—through a collabora | The company behind ChatGPT and the biotech startup have been working to tailor models specifically to identify the pitfalls that may cause a promising molecule to miss its primary endpoint, through a process called reinforcement fine-tuning.